Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35814037)
Watch
English
Kinase inhibitors in the treatment of immune-mediated disease
scientific article published on March 2012
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
title
Kinase inhibitors in the treatment of immune-mediated disease
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
author
Arian Laurence
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
author name string
Apostolos Kontzias
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
Massimo Gadina
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
John J O'Shea
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
publication date
1 March 2012
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
published in
F1000 medicine reports
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
volume
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
page(s)
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
cites work
Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Deciphering the anticancer mechanisms of sunitinib
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Genetic deficiency of Syk protects mice from autoantibody-induced arthritis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
A quantitative analysis of kinase inhibitor selectivity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Interleukin 6: from bench to bedside
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Chronic graft-versus-host disease: Pathogenesis and clinical management.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
The Janus kinases (Jaks)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Chronic myeloid leukemia: current status and controversies.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
A new modality for immunosuppression: targeting the JAK/STAT pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
TOR signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Interleukin signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Role of Jak kinases and STATs in cytokine signal transduction
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Cytokine receptor signaling pathways
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Chronic myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Jaks and STATs: biological implications
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
11 July 2018
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
Sirolimus for solid organ transplantation in children
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
24 September 2018
Circumventing Resistance to Kinase-Inhibitor Therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3297200
retrieved
15 November 2018
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22403586
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identification of an acquired mutation in Jak2 provides molecular insights into the pathogenesis of myeloproliferative disorders
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22403586
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22403586
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.3410/M4-5
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
PMC publication ID
3297200
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
PubMed publication ID
22403586
1 reference
stated in
Europe PubMed Central
PMC publication ID
3297200
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22403586%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit